Monoclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL) is a premium-quality life science research product supplied by Torvigen for laboratory and scientific applications.
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
Uniprot
Q6IBA9
Field of Research
Apoptosis; Tumor immunity
Applications
WB
Organism Species
Homo sapiens (Human)
Concentration
1mg/mL
Buffer
PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Host or Source
Mouse
Source
Monoclonal antibody preparation
Recommended Usage
Western blotting: 0.2-2μg/mL; < br/> Immunohistochemistry: 5-20μg/mL; < br/> Immunocytochemistry: 5-20μg/mL; < br/> Optimal working dilutions must be determined by end user.
